Status:

COMPLETED

Exercise for Women With Peripheral Arterial Disease

Lead Sponsor:

University of Oklahoma

Collaborating Sponsors:

Oklahoma Center for the Advancement of Science and Technology

Milton S. Hershey Medical Center

Conditions:

Peripheral Artery Disease

Claudication

Eligibility:

FEMALE

60-100 years

Phase:

NA

Brief Summary

Hypothesis #1. Supervised exercise rehabilitation will result in greater increases in exercise performance, peripheral vascular function, and health-related quality of life than compared to the attent...

Eligibility Criteria

Inclusion

  • women 60 years of age and older having a positive history of intermittent claudication assessed by the San Diego Claudication Questionnaire
  • exercise limited by intermittent claudication during a screening treadmill test using the Gardner protocol
  • an ankle/brachial index (ABI) \< 0.90 at rest or \< 0.73 immediately following the treadmill exercise test
  • at least one year past menopause

Exclusion

  • absence of PAD (peripheral artery disease)
  • asymptomatic PAD (Fontaine stage I)
  • rest pain due to PAD (Fontaine stage III)
  • tissue loss due to PAD (Fontaine stage IV)
  • medical conditions that are contraindicative for exercise according to the American College of Sports Medicine (e.g., acute myocardial infarction, unstable angina, etc.)
  • use of medications indicated for the treatment of intermittent claudication (cilostazol and pentoxifylline) initiated within three months prior to investigation)
  • cognitive dysfunction (mini-mental state examination score \< 24)
  • active cancer, renal disease, or liver disease
  • a calf skin fold measurement \> 50 mm, because of potential interference with the light path of the near-infrared spectroscopy probe from penetrating the subcutaneous tissue
  • pulse arterial oxygen saturation of the index finger \< 95% because of the potential deleterious effect on calf muscle StO2 from poor pulmonary gas exchange

Key Trial Info

Start Date :

July 1 2009

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

February 1 2016

Estimated Enrollment :

33 Patients enrolled

Trial Details

Trial ID

NCT01241747

Start Date

July 1 2009

End Date

February 1 2016

Last Update

March 1 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Clinical Research Center, Penn State College of Medicine

Hershey, Pennsylvania, United States, 17033